Alnylam Pharmaceuticals (ALNY) Current Taxes (2009 - 2010)

Alnylam Pharmaceuticals (ALNY) posted Current Taxes of $237000.0 for Q3 2010, down 12.87% on a QoQ basis from $272000.0 in Q2 2010.

Alnylam Pharmaceuticals (ALNY) Current Taxes (2009 - 2010) Analysis & Trends

Alnylam Pharmaceuticals' Current Taxes history runs 2 years deep, the most recent figure standing at $237000.0 for Q3 2010.

Quarterly Current Taxes changed N/A year-over-year to $237000.0 in Q3 2010, while the trailing twelve-month figure through Sep 2010 was $237000.0 (changed N/A YoY) and the FY2009 annual result came in at $5.5 million, changed N/A from the prior year.
Current Taxes was $237000.0 for Q3 2010 at Alnylam Pharmaceuticals, down from $272000.0 in the prior quarter.
Across five years, Current Taxes topped out at $5.5 million in Q4 2009 and bottomed at $237000.0 in Q3 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	63.52 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	49.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Alnylam Pharmaceuticals	35.71 Bn	32.70 Bn	959.66 Mn	-

Download Data